Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Intellectual Property net

Intellectual Property net

6 Months Ended

Feb. 28, 2023

Intellectual Property net

Intellectual Property

7. Intellectual Property, net

The following is a list of capitalized US patents held by the Company:

Issued Patent #	Patent Certificate Grant Date	Patent Family
US 9,474,725 B1	10/25/2016	Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof
US 9,839,612 B2	12/12/2017
US 9,972,680 B2	05/15/2018
US 9,974,739 B2	05/22/2018
US 10,084,044 B2	09/25/2018
US 10,103,225 B2	10/16/2018
US 10,381,440	08/13/2019
US 10,374,036	08/06/2019
US 10,756,180	08/25/2020
US 11,311,559	04/26/2022	Compositions and Methods for Enhanced Delivery of Antiviral Agents

A continuity schedule for capitalized patents is presented below:

		February 28,				August 31,
		2023				2022

Balance – beginning		$	488,462			$	364,623
Addition			33,778				131,448
Amortization			(4,510	)			(7,609	)
Balance – ending		$	517,730			$	488,462
Patents are amortized over their 20 year legal life.